11-13 November 2025
Congress Center BaselBasel, Switzerland Philipp BuerlingCEO at Priavoid GmbHSpeaker
Profile
Philipp Buerling is CEO of clinical stage biotech Priavoid based in Dusseldorf Germany. He studied business and IT management and holds an MBA from the University of Dusseldorf. He switched from a corporate track in the logistics industry to life science in 2015 by co-founding NUMAFERM, a pioneering company in recombinant peptide production.
Agenda Sessions
Development of All-D-peptides for the Treatment of Neurodegenerative Disorders
, 10:15View Session